30

Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A

301246 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

15.24CNY-0.44 (-2.81%)

Price History

Full chart

Market Stats

Previous Close15.68
Open15.66
Day Range15.22 – 15.90
52-Week Range14.18 – 35.52
Volume4.80M
Market Cap7.02B
P/E (TTM)24.70
Forward P/E0.00
EPS0.71
Dividend Yield0.29%
Beta1.02
50-Day Avg19.19
200-Day Avg23.24

About

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Shuangxi Xu
  • Employees2.26K
  • HeadquartersNo.8 Hongyuan Road, Huanggang, China, 438600, China
  • Websitehttps://www.hbhypharm.com

Leadership

  • Mr. Shuangxi XuDirector and General Manager · b. 1966
  • Mr. Kefeng ZengFinancial Officer · b. 1985
  • Mr. Yonghua XiaoDirector, Secretary of the Board & Accounting Supervisor · b. 1977
  • Mr. Zhihua DengDeputy GM & Non-Independent Director · b. 1970
  • Mr. Siyuan ChengDeputy GM & Non-Independent Director · b. 1973

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.58B2.06B2.05B1.77B1.94B
Growth (%)-+30.79%-0.43%-13.83%+9.53%
Cost of Revenue1.05B1.58B1.79B1.55B1.58B
Gross Profit530.72M481.34M266.87M215.77M364.15M
Gross Margin33.64%23.32%12.99%12.19%18.78%
Operating Expense156.19M151.58M156.57M129.66M185.74M
Operating Income374.53M329.76M110.29M86.11M178.41M
Operating Margin23.74%15.98%5.37%4.86%9.20%
EBITDA-574.61M268.83M250.32M361.99M
EBITDA Margin-27.84%13.08%14.14%18.66%
Net Income493.85M434.80M87.17M51.47M119.05M
Net Income Margin31.30%21.07%4.24%2.91%6.14%
R&D48.71M64.01M68.82M59.18M83.90M
R&D as % of Total Revenue3.09%3.10%3.35%3.34%4.33%
Interest Expense2.38M6.83M13.40M12.00M13.79M
Interest Expense % of Total Revenue0.15%0.33%0.65%0.68%0.71%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.43B3.88B5.65B5.82B6.16B
Total Liabilities754.27M1.76B1.29B1.46B1.71B
Total Equity1.68B2.11B4.36B4.36B4.46B
Cash120.43M395.19M421.86M745.59M472.74M

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow196.10M214.99M35.25M-15.81M-184.96M
Capital Expenditure259.01M507.09M474.64M160.20M156.09M
Free Cash Flow-62.92M-292.10M-439.39M-176.01M-341.06M
Dividends Paid2.22M14.97M53.80M30.86M28.07M
FCF to OCF-32.08%-135.87%-1246.48%1113.28%184.39%
Dividend Paid to FCF-3.52%-5.13%-12.24%-17.54%-8.23%

Earnings

Report DateMar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------
EPS Actual0.160.000.08-0.020.080.010.000.040.02-0.040.010.300.360.03
Surprise--------------
Timing--------------

Key Statistics & Ratios

Market Cap7.02B
Enterprise Value6.32B
Trailing P/E24.70
Forward P/E0.00
Price / Sales2.92
Price / Book1.57
EPS0.71
Book Value11.61
Revenue (TTM)2.40B
Gross Profit (TTM)535.26M
EBITDA513.24M
Profit Margin11.72%
Operating Margin3.68%
Return on Equity6.26%
Return on Assets3.09%
Shares Outstanding400.01M
Shares Float159.03M
Beta1.02
Dividend Yield0.29%
Dividend Rate0.05
Payout Ratio7.06%

Dividends

20261×
0.05Jun 26, 2026
20251×
0.03Jun 25, 2025
20241×
0.05Jul 9, 2024
20231×
0.10Jun 6, 2023